The haemodynamic effects of intracerebroventricular (icv) administration of neuropeptide Y
(NPY) in urethane-anaesthetized rats were studied. In Sprague-Dawley rats, NPY increased …

The effects of neuropeptide Y (NPY, 10 μg/kg bolus iv) on renal, mesenteric and hindlimb
blood flow were determined in intact conscious rabbits with chronically implanted Doppler …

Neuropeptide Y is released together with norepinephrine from sympathetic nerve terminals
during conditions of increased sympathetic activity. Neuropeptide Y is known to inhibit vagal …

Neuropeptide Y is one of the most abundant mammalian neuropeptides identified to date.
The possible actions of neuropeptide Y, that is co-localized and released with …

Background Chronic heart failure is associated with increased sympathetic nerve activity
and elevated plasma neuropeptide Y levels. The aim of this study was to investigate whether …

Splenic nerve stimulation (10 Hz for 2 min) caused a perfusion-pressure increase, a volume
reduction and an increase in the output of neuropeptide Y-like immunoreactivity (NPY-LI) …

Neuropeptide Y (NPY), which co-exists with noradrenaline (NA) in postganglionic
sympathetic nerves, was able to potentiate NA-evoked constriction in certain isolated rabbit …

Beta‐blockers are the only anti‐arrhythmic drugs that improve mortality post myocardial
infarction (MI), but a significant risk of ventricular arrhythmia remains. We have shown that …

Neuropeptide Y is a vasoactive peptide and is widely distributed throughout the central and
peripheral nervous systems. Neuropeptide Y is coreleased with noradrenaline by …